Home » News

Visual Paradigm for UML 8.2 Service Pack 1 Released

12 July 2011 No Comment

July 04, 2011 – Visual Paradigm International Limited announced today the release of Visual Paradigm for UML 8.2 Service Pack 1 (VP-UML 8.2 SP1), an award winning UML CASE Tool.

VP-UML 8.2 SP1 introduces a number of new features, which includes:
* Model quality
* ElaborView on Web
* ClearCase integration

Enhancements to VP-UML 8.2 includes:
* Support namespace in C++ code synchronization
* Apply color for all existing model elements with same model type
* Enrich Use Case details configuration
* Transit model element consider also nickname
* Support open and close folder in published project
* Support boolean type tagged values
* Direct generate RACI chart from BPD

Pricing and Availability

VP-UML 8.2 SP1 is now available through the Visual Paradigm online shop and through Visual Paradigm authorized resellers. VP-UML is available under both single-seat (developer-based) and floating licenses. Single-seat licenses are available from US $99.00 for the Modeler Edition to US $1399.00 for the Enterprise Edition. Alternatively, these licenses can be purchased with a one-year software maintenance contract for prices starting from US $118.50 up to US $1678.50. A floating license is available from US $128.50 to US $1818.50, or US $154.00 to US $2182.00 including a one-year software maintenance contract. Both minor and major version upgrades are covered by the software maintenance contracts.

Visual Paradigm for UML

Visual Paradigm for the Unified Modeling Language (VP-UML) is a UML tool. The tool is designed for a wide range of users including software engineers, system analysts, business analysts and system architects, or for anyone who is interested in reliably building large-scale software systems using an object-oriented approach. In addition, VP-UML supports the latest standards of UML notation. The Visual Paradigm for UML product home page is located on the Web at http://www.visual-paradigm.com/product/vpuml/.

Related Content:

  • No Related Content

Comments are closed.